134 related articles for article (PubMed ID: 21736587)
1. Safety of oral robenacoxib in the cat.
King JN; Hotz R; Reagan EL; Roth DR; Seewald W; Lees P
J Vet Pharmacol Ther; 2012 Jun; 35(3):290-300. PubMed ID: 21736587
[TBL] [Abstract][Full Text] [Related]
2. Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.
King JN; Arnaud JP; Goldenthal EI; Gruet P; Jung M; Seewald W; Lees P
J Vet Pharmacol Ther; 2011 Jun; 34(3):298-311. PubMed ID: 21492194
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo inhibition of COX isoforms by robenacoxib in the cat: a comparative study.
Schmid VB; Seewald W; Lees P; King JN
J Vet Pharmacol Ther; 2010 Oct; 33(5):444-52. PubMed ID: 20840388
[TBL] [Abstract][Full Text] [Related]
4. Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations.
Toutain CE; Brossard P; King SB; Helbig R
BMC Vet Res; 2018 Aug; 14(1):242. PubMed ID: 30119677
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/pharmacodynamic modelling of robenacoxib in a feline tissue cage model of inflammation.
Pelligand L; King JN; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2012 Feb; 35(1):19-32. PubMed ID: 21767277
[TBL] [Abstract][Full Text] [Related]
6. Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats.
Heit MC; Stallons LJ; Seewald W; Thompson CM; Toutain CE; King SB; Helbig R
BMC Vet Res; 2020 Sep; 16(1):355. PubMed ID: 32988403
[TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2.
King JN; Dawson J; Esser RE; Fujimoto R; Kimble EF; Maniara W; Marshall PJ; O'Byrne L; Quadros E; Toutain PL; Lees P
J Vet Pharmacol Ther; 2009 Feb; 32(1):1-17. PubMed ID: 19161451
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs.
Toutain CE; Heit MC; King SB; Helbig R
BMC Vet Res; 2017 Nov; 13(1):359. PubMed ID: 29179750
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs.
Friton G; Thompson CM; Karadzovska D; King S; King JN
BMC Vet Res; 2017 Jun; 13(1):197. PubMed ID: 28651573
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib.
Giraudel JM; Toutain PL; King JN; Lees P
J Vet Pharmacol Ther; 2009 Feb; 32(1):31-40. PubMed ID: 19161453
[TBL] [Abstract][Full Text] [Related]
11. Effects of route of administration and feeding schedule on pharmacokinetics of robenacoxib in cats.
King JN; Jung M; Maurer MP; Schmid VB; Seewald W; Lees P
Am J Vet Res; 2013 Mar; 74(3):465-72. PubMed ID: 23438125
[TBL] [Abstract][Full Text] [Related]
12. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
Pelligand L; King JN; Hormazabal V; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2014 Aug; 37(4):354-66. PubMed ID: 24628410
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney.
Pelligand L; Suemanotham N; King JN; Seewald W; Syme H; Smith K; Lees P; Elliott J
BMC Vet Res; 2015 Dec; 11():296. PubMed ID: 26634699
[TBL] [Abstract][Full Text] [Related]
14. Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.
Schmid VB; Spreng DE; Seewald W; Jung M; Lees P; King JN
J Vet Pharmacol Ther; 2010 Apr; 33(2):118-31. PubMed ID: 20444036
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
Lees P; Toutain PL; Elliott J; Giraudel JM; Pelligand L; King JN
J Vet Pharmacol Ther; 2022 Jul; 45(4):325-351. PubMed ID: 35460083
[TBL] [Abstract][Full Text] [Related]
16. Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.
Reymond N; Speranza C; Gruet P; Seewald W; King JN
J Vet Pharmacol Ther; 2012 Apr; 35(2):175-83. PubMed ID: 21480932
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs.
Friton G; Thompson C; Karadzovska D; King S; King JN
J Vet Intern Med; 2017 May; 31(3):832-841. PubMed ID: 28514527
[TBL] [Abstract][Full Text] [Related]
18. Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial.
Speranza C; Schmid V; Giraudel JM; Seewald W; King JN
BMC Vet Res; 2015 Mar; 11():79. PubMed ID: 25880535
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs.
Borer LR; Seewald W; Peel JE; King JN
J Vet Pharmacol Ther; 2017 Apr; 40(2):148-157. PubMed ID: 27493016
[TBL] [Abstract][Full Text] [Related]
20. Comparison of oral robenacoxib and ketoprofen for the treatment of acute pain and inflammation associated with musculoskeletal disorders in cats: a randomised clinical trial.
Sano T; King JN; Seewald W; Sakakibara N; Okumura M
Vet J; 2012 Aug; 193(2):397-403. PubMed ID: 22430026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
